Global Anesthesia Drug Market Size study, by Type(General Anesthesia, Spinal Anesthesia, Peripheral Nerve Block, Saddle Block Anesthesia, Interscalene Block, IV Regional Anesthesia), by Routes of Administration (Injection, Inhalation), by Product(Propofol, Sevoflurane, Desflurane, Remifentanil, Midazolam, Dexmedetomidine, Others) and Regional Forecasts 2018-2025

November 2018 | 200 pages | ID: G9A693B8100EN
Bizwit Research & Consulting LLP

Abstracts

Global Anesthesia Drug Market to reach USD xxx billion by 2025.

Global Anesthesia Drug Market valued approximately USD xxx billion in 2017 is anticipated to grow with a healthy growth rate of more than 4.2% over the forecast period 2018-2025. The Anesthesia defined as the temporary condition of unconsciousness, loss of memory, lack of pain and muscle relaxation. In the medical terms the anesthesia has taken its pivotal place in the treatment of diseases and surgeries. In the present scenario, the rising aging population and enhancing medical utility of anesthesia drugs in the medical care and surgeries is anticipated to increase in the forthcoming years that means there will be immense demand of anesthesia drugs considering the global scenario. According to medical experts the risk of complications during anesthesia are boosted by the factors such as smoking, high blood pressure, diabetes, obstructive sleep arena and lung related to heart or lung related medical conditions, and drug allergies or the past reactions related to anesthesia. The routes of administration of anesthesia drugs market includes the injection and inhalation. The Injection way of the anesthesia drugs in majorly prevalent in the anesthesia drugs market. The Inhalation way is on the verge of development and growth as it is being studied for the innovations. In few cases both the routes of administration such as injection and inhalation are used together to anesthetize the patient or the individual. The Patient who is administered by these drugs results into loosing consciousness and does not feel the pain after and during surgery & then wakes up with the short term memory loss which is also known as amnesia. The Anesthesiologists in the medical world prefer to have the utility of one or more combination of drugs which directly depends on the physical condition of the patient and experience of the physician or surgeon who is intended to treat the individual. The Lack of healthcare facilities in the underdeveloped countries such as sub-saharan and African countries such as Botswana, Swaziland and Uganda the presence of few anesthetic nurses and experienced surgeons is restraining the growth of the anesthesia drug market. In the present scenario, there is a lack of precise or standard procedure or technique in anesthesia management .The high cost of health procedures and the branded drugs is a major challenge which is limiting the growth of the anesthesia drug market.

The regional analysis of Global Anesthesia Drug Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the fastest growing region across the world in terms of market share. Whereas, owing to the countries such as China, Japan, and India, Asia Pacific region is anticipated to be the dominating region over the forecast period 2018-2025.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

• General Anesthesia
• Spinal Anesthesia
• Peripheral Nerve Block
• Saddle Block Anesthesia
• Interscalene Block
• IV Regional Anesthesia

Routes of Administration Segment include:

Injection Market

Inhalation Market
Product Segment Include:

• Propofol
• Sevoflurane
• Desflurane
• Remifentanil
• Midazolam
• Dexmedetomidine
• Others

By Regions:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• Asia Pacific
• China
• India
• Japan
• Latin America
• Brazil
• Mexico
• Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025

The leading market players mainly include-

• ABBOTT LABORATORIES
• BAXTER INTERNATIONAL PLC
• NOVARTIS
• MYLAN NV
• HIKMA PHARMACEUTICALS PLC
• OTHERS

Target Audience of the Global Anesthesia Drug Market in Market Study:

• Key Consulting Companies & Advisors
• Large, medium-sized, and small enterprises
• Venture capitalists
• Value-Added Resellers (VARs)
• Third-party knowledge providers
• Investment bankers
• Investors

Contents

TABLE OF CONTENTS

CHAPTER 1. GLOBAL ANESTHESIA DRUG MARKET DEFINITION AND SCOPE

1.1. Research Objective
1.2. Market Definition
1.3. Scope of The Study
1.4. Years Considered for The Study
1.5. Currency Conversion Rates
1.6. Report Limitation

CHAPTER 2. RESEARCH METHODOLOGY

2.1. Research Process
  2.1.1. Data Mining
  2.1.2. Analysis
  2.1.3. Market Estimation
  2.1.4. Validation
  2.1.5. Publishing
2.2. Research Assumption

CHAPTER 3. EXECUTIVE SUMMARY

3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
3.2. Key Trends

CHAPTER 4. GLOBAL ANESTHESIA DRUG MARKET DYNAMICS

4.1. Growth Prospects
  4.1.1. Drivers
  4.1.2. Restraints
  4.1.3. Opportunities
4.2. Industry Analysis
  4.2.1. Porter’s 5 Force Model
  4.2.2. PEST Analysis
  4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion

CHAPTER 5. GLOBAL ANESTHESIA DRUG MARKET, BY TYPE

5.1. Market Snapshot
5.2. Market Performance - Potential Model
5.3. Global Anesthesia Drug Market, Sub Segment Analysis
  5.3.1. General Anesthesia
    5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  5.3.2. Spinal Anesthesia
    5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  5.3.3. Peripheral Nerve Block
    5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  5.3.4. Saddle Block Anesthesia
    5.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    5.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  5.3.5. Interscalene Block
    5.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  5.3.6. IV Regional Anesthesia Market
    5.3.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)
Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 6. GLOBAL ANESTHESIA DRUG MARKET, BY ROUTES OF ADMINISTRATION

6.1. Market Snapshot
6.2. Market Performance - Potential Model
6.3. Global Anesthesia Drug Market, Sub Segment Analysis
  6.3.1. Injection
    6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  6.3.2. Inhalation
    6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 7. GLOBAL ANESTHESIA DRUG MARKET, BY PRODUCT

7.1. Market Snapshot
7.2. Market Performance - Potential Model
7.3. Global Anesthesia Drug Market, Sub Segment Analysis
  7.3.1. Propofol
    7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.3.2. Sevoflurane
    7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.3.3. Desflurane
    7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.3.4. Remifentanil
    7.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.3.5. Midzalom
    7.3.5.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.5.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.3.6. Dexmedetomidine
    7.3.6.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.6.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
  7.3.7. Others
    7.3.7.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    7.3.7.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 8. GLOBAL ANESTHESIA DRUG MARKET, BY REGIONAL ANALYSIS

8.1. Anesthesia Drug Market, Regional Market Snapshot (2015-2025)
8.2. North America Anesthesia Drug Market Snapshot
  8.2.1. U.S.
    8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.2.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.1.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.2.2. Canada
    8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.2.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.2.2.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3. Europe Anesthesia Drug Market Snapshot
  8.3.1. U.K.
    8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.1.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.3.2. Germany
    8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.2.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.3.3. France
    8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.3.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.3.4. Rest of Europe
    8.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.3.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.3.4.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4. Asia Anesthesia Drug Market Snapshot
  8.4.1. China
    8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.1.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.4.2. India
    8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.2.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.4.3. Japan
    8.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.3.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.3.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.4.4. Rest of Asia Pacific
    8.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.4.4.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.4.4.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5. Latin America Anesthesia Drug Market Snapshot
  8.5.1. Brazil
    8.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.5.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.1.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.5.2. Mexico
    8.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.5.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.5.2.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6. Rest of The World
  8.6.1. South America
    8.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.6.1.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.6.1.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)
  8.6.2. Middle East and Africa
    8.6.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
    8.6.2.2. Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
    8.6.2.3. Product breakdown estimates & forecasts, 2015-2025 (USD Billion)

CHAPTER 9. COMPETITIVE INTELLIGENCE

9.1. Company Market Share (Subject to Data Availability)
9.2. Top Market Strategies
9.3. Company Profiles
  9.3.1. Astra Zeneca
    9.3.1.1. Overview
    9.3.1.2. Financial (Subject to Data Availability)
    9.3.1.3. Product Summary
    9.3.1.4. Recent Developments
  9.3.2. Abott Laboratories
  9.3.3. Baxter International Inc
  9.3.4. Boehringer Ingelheim
  9.3.5. Eisai Co Ltd
  9.3.6. Fresenius SE & Co KGAA
  9.3.7. Hospira Inc
  9.3.8. Mylan NV
  9.3.9. Novartis
  9.3.10. Par Pharmaceuticals Companies Inc
  9.3.11. Piramal
  9.3.12. Pfizer
  9.3.13. Roche
  9.3.14. Hikma Pharmaceuticals PLC
  9.3.15. SAS Institute Inc